Acelyrin announces positive results from Phase 3 trial of izokibep
PremiumThe FlyAcelyrin announces positive results from Phase 3 trial of izokibep
2M ago
Acelyrin announces PoC data from Phase 1/2 trial of lonigutamab
Premium
The Fly
Acelyrin announces PoC data from Phase 1/2 trial of lonigutamab
2M ago
Acelyrin price target lowered to $6 from $13 at Morgan Stanley
Premium
The Fly
Acelyrin price target lowered to $6 from $13 at Morgan Stanley
3M ago
Acelyrin reports Q2 EPS (86c), consensus (75c)
PremiumThe FlyAcelyrin reports Q2 EPS (86c), consensus (75c)
3M ago
SLRN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SLRN Upcoming Earnings Report: What to Expect?
3M ago
Wells upgrades Acelyrin to Overweight with shares trading below cash
Premium
The Fly
Wells upgrades Acelyrin to Overweight with shares trading below cash
4M ago
Acelyrin management to meet virtually with Piper Sandler
PremiumThe FlyAcelyrin management to meet virtually with Piper Sandler
6M ago
SLRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
SLRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
ACELYRIN, INC. Appoints Mina Kim as New CEO
Premium
Company Announcements
ACELYRIN, INC. Appoints Mina Kim as New CEO
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100